Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M. M. Brentani"'
Autor:
M. M. Brentani, M. H. H. Federico, M. Yamamoto, D. A. Maria, M. L. H. Katayama, S. Sonohara, R. A. Roela
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 86, Pp 43-50 (1991)
Externí odkaz:
https://doaj.org/article/e6c004ea8a084015b1d4448d59777f5c
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 86, Pp 119-120 (1991)
Externí odkaz:
https://doaj.org/article/6c23731c7c364fe19651cdb2483332b7
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 86, Pp 121-122 (1991)
Externí odkaz:
https://doaj.org/article/a3c9528064c249f8b5b6688ee337c58b
Publikováno v:
Arquivos de Neuro-Psiquiatria, Vol 43, Iss 4, Pp 365-371 (1985)
Cytosolic estrogen (ER), progesterone (PR), androgen (AR) and glucocorticoid receptors (GR) were evaluated in 10 meningiomas using a dextran charcoal coated method. We consider as positive specific receptor values >10fMol/mg protein. In this study 20
Externí odkaz:
https://doaj.org/article/3dbaab27b7b9451f8c7c7df9ca6e8277
Autor:
Sueli Nonogaki, M. M. Brentani, F. S. Pasini, R. Malagoli, M. A. Stiepcich, A. F. Logullo, Fernando Augusto Soares
Publikováno v:
Laboratory Investigation. 94:34-90
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(5)
Tumor cells and their surrounding microenvironment produce a variety of growth factors and proteolytic enzymes to promote tumor growth and metastasis. We have recently identified a novel factor, termed com1, which is up-regulated in human breast carc
Autor:
R R, Brentani, M M, Brentani
Publikováno v:
Revista do Hospital das Clinicas. 50(4)
Oncogene amplification and loss of heterozygosity for tumor suppressor genes have been correlated with prognosis in a variety of human tumors. Detection of mutations in tumor suppressor genes have been found to serve as risk factor determinants in ga
Publikováno v:
Oncology. 50(6)
c-erbB-2 DNA amplification and mRNA expression were analyzed by dot and Southern blots in 65 human primary breast tumors. Gene amplification was observed in 21 of 65 (32.3%) and elevated levels of c-erbB-2 transcript in 14 of 60 (23.3%) of the tumors
Autor:
M, Yamamoto, M H, Federico, D A, Maria, M A, Koike, M L, Katayama, R A, Roela, S, Sonohara, M M, Brentani
Publikováno v:
International journal of hematology. 58(3)
A 125I-labeled 120-kDa fibronectin fragment (FN120) containing the RGD binding site was employed to assess FN120 receptor levels in control and dimethylsulfoxide (DMSO)-differentiated HL60 cells, as well as in leukemic peripheral and bone marrow blas
Autor:
M M, Brentani
Publikováno v:
Revista paulista de medicina. 111(4)